Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Year: 2018
Type: article
Abstract: T cell responses while broadening their epitope recognition to tumor-associated antigens, neoantigens, and intact whole tumor cells. Combination chemoimmunotherapy with nanodiscs plus anti-programmed death 1 therapy induced complete regression of established CT26 and MC38 colon carcinoma tumors in 80 to 88% of animals and protected survivors against tumor recurrence. Our work provides a new, generalizable framework for using nanoparticle-based chemotherapy to initiate antitumor immunity and sensitize tumors to immune checkpoint blockade.
Source: Science Advances
Institution: University of Michigan
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,500
Funders: National Science Foundation, U.S. Department of Defense, American Heart Association, Melanoma Research Alliance, Massachusetts Institute of Technology, Emerald Foundation, National Institutes of Health, Office of the Director, University of North Carolina at Chapel Hill, National Heart, Lung, and Blood Institute, NIH Office of the Director, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering, DOD Peer Reviewed Cancer Research Program
Awards: HDL-Loaded Nanoparticles for Glioma Therapeutics, KLF14 and Cardiovascular Disease, The use of synthetic high density lipoproteins as carriers to regulate PCSK9 for LDL management, Novel approaches for immunotherapy against melanoma, Elicitation of mucosal immune responses against HIV, G3488383117, CAREER: Engineering multilamellar vaccine platforms for vaccination against HIV, G4630834455, Synthetic HDL-mediated atheroma targeted delivery of LXR agonists for regression of atherosclerosis, G5289408919, Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme, Engineering Nanomaterials to Prime Immunity
OpenAlex ID: W2802834278
